Enlivex Therapeutics
ENLV
ENLV
3 hedge funds and large institutions have $169K invested in Enlivex Therapeutics in 2018 Q2 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
3
Holders Change
-1
Holders Change %
-25%
% of All Funds
0.07%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Renaissance Technologies
New York
|
+$6.71K |
Top Sellers
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$38K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$173 |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Renaissance Technologies
New York
| $165K | +$6.71K | +512 | +4% |
|
|
2
UBS Group
Zurich,
Switzerland
| $4K | -$173 | -12 | -4% |
|
|
3
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$38K | -2,402 | Closed |
|